JAK2 V617F突变在原发性血小板增多症中的临床意义 - Suppr

Suppr

超能文献

Clinical implications of the JAK2 V617F mutation in essential thrombocythemia.

作者信息

Antonioli E, Guglielmelli P, Pancrazzi A, Bogani C, Verrucci M, Ponziani V, Longo G, Bosi A, Vannucchi A M

出版信息

Leukemia. 2005 Oct;19(10):1847-9. doi: 10.1038/sj.leu.2403902.

DOI:10.1038/sj.leu.2403902

PMID:16079890

Abstract

摘要

相似文献

Clinical implications of the JAK2 V617F mutation in essential thrombocythemia.

Leukemia. 2005 Oct;19(10):1847-9. doi: 10.1038/sj.leu.2403902.

Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders.

Leukemia. 2006 Jun;20(6):1181-3. doi: 10.1038/sj.leu.2404214.

The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia.

Br J Haematol. 2006 Jan;132(2):244-5. doi: 10.1111/j.1365-2141.2005.05858.x.

Genetic heterogeneity of granulocytes for the JAK2 V617F mutation in essential thrombocythaemia: implications for mutation detection in peripheral blood.

Pathology. 2006 Aug;38(4):336-42. doi: 10.1080/00313020600820906.

The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS).

Blood. 2006 Sep 1;108(5):1781-2. doi: 10.1182/blood-2006-03-008227.

JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance.

Br J Haematol. 2005 Oct;131(2):208-13. doi: 10.1111/j.1365-2141.2005.05764.x.

JAK2 V617F mutation analysis in different myeloid lineages (granulocytes, platelets, CFU-MK, BFU-E and CFU-GM) in essential thrombocythemia patients.

Leukemia. 2006 Oct;20(10):1903-5. doi: 10.1038/sj.leu.2404341. Epub 2006 Aug 3.

JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status.

Eur J Haematol. 2006 Sep;77(3):210-6. doi: 10.1111/j.1600-0609.2006.00688.x.

Limited effects on JAK2 mutational status after pegylated interferon alpha-2b therapy in polycythemia vera and essential thrombocythemia.

Haematologica. 2006 Sep;91(9):1281-2.

Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia.

Pediatr Blood Cancer. 2008 Dec;51(6):802-5. doi: 10.1002/pbc.21730.

引用本文的文献

The Association Between Janus Kinase 2 and Factor V Leiden Mutations and Thrombotic Complications in Patients With Myeloproliferative Disorders: A Study From Saudi Arabia.

Cureus. 2024 Nov 25;16(11):e74401. doi: 10.7759/cureus.74401. eCollection 2024 Nov.

Relation of V617F allele burden and coronary calcium score in patients with essential thrombocythemia.

Radiol Oncol. 2024 Oct 4;58(4):565-572. doi: 10.2478/raon-2024-0036. eCollection 2024 Dec 1.

Philadelphia-Negative MPN: A Molecular Journey, from Hematopoietic Stem Cell to Clinical Features.

Medicina (Kaunas). 2021 Sep 30;57(10):1043. doi: 10.3390/medicina57101043.

IRF4 and IRF8 expression are associated with clinical phenotype and clinico-hematological response to hydroxyurea in essential thrombocythemia.

Front Med. 2022 Jun;16(3):403-415. doi: 10.1007/s11684-021-0858-1. Epub 2021 Jul 31.

Retrospective analysis of the clinical features of 172 patients with -negative chronic myeloproliferative neoplasms.

Mol Cytogenet. 2020 Feb 17;13:8. doi: 10.1186/s13039-020-0471-z. eCollection 2020.

JAK2 and Beyond: Mutational Study of JAK2V617 in Myeloproliferative Disorders and Haematological Malignancies in Kashmiri population.

Asian Pac J Cancer Prev. 2019 Dec 1;20(12):3611-3615. doi: 10.31557/APJCP.2019.20.12.3611.

A Case of Essential Thrombocythemia and IgA Nephropathy with Literature Review of the Concurrence.

Case Rep Oncol Med. 2019 Sep 2;2019:5086963. doi: 10.1155/2019/5086963. eCollection 2019.

Guideline on myeloproliferative neoplasms: Associacão Brasileira de Hematologia, Hemoterapia e Terapia Cellular: Project guidelines: Associação Médica Brasileira - 2019.

Hematol Transfus Cell Ther. 2019 Jul;41 Suppl 1(Suppl 1):1-73. doi: 10.1016/j.htct.2019.03.001. Epub 2019 May 10.

Development of a high resolution melting analysis assay for rapid identification of JAK2 V617F missense mutation and its validation.

Exp Hematol Oncol. 2019 Apr 30;8:10. doi: 10.1186/s40164-019-0134-0. eCollection 2019.

Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms.

J Thromb Thrombolysis. 2018 May;45(4):516-528. doi: 10.1007/s11239-018-1623-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验